Kelowna, British Columbia–(Newsfile Corp. – November 19, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that the Company is now in production to have dispensary shelves stocked with the Company’s Proprietary organic products. Highly anticipated among dispensaries and enthusiasts, 25,000 live resin and distillate vape pens are set for distribution right ahead of the holiday rush.

“Our goal has been to retain the true essence of the plant and preserve that quality in a truly premium organic line, bringing to market a top-quality flavorful selection sure to compete well against the top contenders in its league.” stated, Rahim Mohamed, President. Products being prepared for launch are expected to hit shelves the last week of November.

These exclusive blends are sourced from exquisite sources like FIORE – TRIPLE CERTIFIED to produce specific products like Diamonds Live Resin, Sugar Wax and Live Resin Vape Pen formulations.

FIORE was born out of the necessity to bring exceptional cannabis genetics, growing standards and passion to commercial cannabis – keeping craft cannabis alive. Having passed through the ranks of the cannabis industry over the last 15 years, Management has taken the experience, the knowledge and the pride from growing exceptional cannabis and delivered it to the Nevada marketplace, enabling consumers with the opportunity to experience the simplicity, elegance and quality, in the finished product, that is decades in the making.

Diamante Labs was founded on the determination to formulate high quality extracts by using closed loop hydrocarbon processes. Based on research, management believes that up to 100% of products produced will be sold almost immediately upon delivery to dispensaries.

Vape Pen wholesale prices for Citations premium products are as follows:

Diamante Labs Live Resin Disposable Vape Pen, 0.30 grams per pen $22.00 Diamante Labs Live Resin cartridge, 0.50 grams $35.00 each
Superior Extracts distillate Disposable Vape Pen, 0.30 grams $13.00 per pen Superior Extracts distillate cartridge, 0.50 grams $22.00 each

Superior Brand will be mostly Distillate to start and Diamante Labs Vape Pen will be mostly Live Resin to start. Citation will begin to diversify its product lines in the upcoming months to offer our customers a wide range of premium quality extracts. Our focus will be on our Triple-Certified Organic Diamante Labs products that are healthier for the end user.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
RM@citationgrowth.com
1-877-438-5448 Extension 718

Paul Searle, Corporate Communications
psearle@citationgrowth.com
1-877-438-5448 Extension 714

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Amendments to Celista Joint Venture Agreement Facilitate $6.3 Million in Capital to Conclude Construction of 10,000 Square Foot Celista Property

Kelowna, British Columbia–(Newsfile Corp. – November 12, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that it has entered into an amended agreement (the “Amended Agreement”) with 1186626 B.C. Ltd. (“1186626 “) in connection with its joint venture agreement (the “JV Agreement”) on the Company’s Celista property located in British Columbia (the “Celista Project”).

Management has been resolute in their discovery of non-dilutive financing opportunities, in their commitment to maintain the integrity of the capital stricture. “We are very pleased with how this partnership has evolved. We have a big vision for this project, and are ready to move forward, full speed ahead, having the funding set in place.” Stated, Rahim Mohamed, President. The Company is currently in the process of constructing the first two of ten buildings, totaling 100,000 square feet of cultivation and processing space at this project.

Pursuant to the JV Agreement, 1186626 was to provide a capital contribution in the aggregate amount of $10 million (the “Capital Contribution”) to be delivered to the Company in four tranches of $2.5 million for the construction of ten 10,000 square foot cannabis production facilities. From the date of the agreement until the third year that all ten facilities are fully operational and in full production, project distributable cash flow (the “Project Distributable Cash”) will be allocated as to 50% each to the Company and 1186626, and 100% to the Company thereafter.

Under the terms of the Amended Agreement, the Capital Contribution will be $6,350,000 (the “Amended Contribution) to finance the completion of the Company’s 10,000 square foot facility, and the Project Distributable Cash has been amended as to 80% to 1186626 and 20% to the Company until the first year anniversary that 1186626’s Amended Contribution has been fully repaid, and 100% to the Company thereafter.

All other terms and conditions of the JV Agreement remain the same.

In consideration of the Amended Agreement, the Company agreed to terminate its joint venture agreement with 1186626 with respect to the Chase property located in British Columbia. Additionally, further to the Company’s press release dated April 22, 2019, the Company agreed to assign all of its right, title, interest in and to the Bud For You Inc. to 1186626.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to

include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President

RM@citationgrowth.com

1-877-438-5448 Extension 718

Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties;

market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Emerging Nevada marketplace is this company’s initial focus following acquisition

Nevada’s cannabis market is worth USD$580 million in its first year of legal recreational use

Following its American Cannabis Cultivators (ACC) acquisition, Citation Growth Corp. is focused on organic production, genetics and distribution in Nevada

Organic production is a crucial differentiator for Citation Growth Corp., Nevada’s only triple-certified organic cannabis producer

Nevada’s cannabis market hit USD$639 million in sales in its most recent fiscal year, which is a 20 per cent jump from USD$530 million over the same period last year. The key difference is that 2019 was the state’s first full year where recreational cannabis use was legal. So, with more than 60 million tourists visiting Nevada each year, the potential for growth is momentous.

Over the last few years, Canada and several U.S. states have legalized recreational cannabis, however, the resulting rush of companies into the nascent marketplace has generated volatile results for early investors. This has prompted some analysts to recommend looking at the industry through a new lens and consider cannabis as a long-term investment with the potential to pay off over time as companies mature, and especially as cannabis use eats into alcohol and pharmaceutical sales.

Entering the cannabis market as a triple-threat contender 

With a lucrative market and endless opportunities, Canada’s Citation Growth Corp. (CSE: CGRO, OTCQX: CGOTF) hopes to stake an early but lasting claim with an integrated, multi-state seed-to-sale operation focused on cultivating quality, certified-organic product lines.

Producing triple-certified organic cannabis makes us the only facility in the country with this designation. It allows the consumer to feel comfortable with the product they are purchasing while being confident it sets high standards for quality and safety.”

Howard Misle, CEO, Citation Growth Corp.

The company completed the acquisition of American Cannabis Cultivators in August this year, bringing it a rich collection of genetic strains and new CEO, Howard Misle’s 16-year track cultivation record. Plus, Citation also inherited a substantial foothold in Nevada’s tremendous marketplace with licenses for up to 569,600-sq.-ft. of cultivation, making the company one of the largest licensed footprint holders in a state that has a current moratorium on licenses.

Establishing strong operations in a state popular with year-round tourists will set the company up for financial stability and will thus allow growth into other marketplaces where it already holds cultivation and distribution licenses. Citation’s president, Rahim Mohamed, notes, “Last year, approximately 62 million tourists entered the state of Nevada, predominantly in the city of Las Vegas. That is nearly double the population of Canada moving through one city in one year.”

Mohamed explains that the company has an established cultivation facility in Pahrump, about 50 minutes outside of Vegas, and has just completed construction of a production facility closer to the city located in North Las Vegas in Oct. 2019. Facilities in North Las Vegas each have three organic certifications: EnvirOrganic Farm Certification, Certified Kind and Clean Green Certified. These organic certifications are also underway in Pahrump.

Setting a new standard for organic production 

Citation’s certifications make the company the only triple-certified organic cannabis producer in the state, a key differentiator with health-conscious cannabis consumers.

“Producing triple-certified organic cannabis makes us the only facility in the country with this designation,” adds CEO, Howard Misle. “It allows the consumer to feel comfortable with the product they are purchasing while being confident it sets high standards for quality and safety.”

The promise to produce premium cannabis for consumers comes at an important time when other cannabis producers have faced backlash over tainted products hitting the market without being detected. Canopy Growth Corp and OrganiGram Holdings have both faced the consequences of selling tainted products to consumers back in 2017.

Despite the negativity hitting the press around cannabis, Citation is setting a new standard for its quality control measures in every jurisdiction that it operates in. The company cultivates specific genetics using state-of-the-art processes and grows its product in small batches in living soil. Growing cannabis in smaller batches in controlled environments allows Citation to maintain quality and minimize losses caused by any issues, which has dogged some producers in this new industry. Additionally, the company cures its end product instead of adhering to the more typical dehydration method.

Citation’s cannabis products will hit the shelves quickly after cultivation, satisfying increasing consumer demand with a fresh product. The company also has six brands to offer consumers: Blunt Box, Gardens of WeEden, Superior, Fiore triple-certified, Diamante Labs and PureCloud 9.

Citation cultivates every three days in Pahrump and every seven days in North Las Vegas, and all of its cannabis is pre-sold, meaning the company is not storing any of its cultivated cannabis for long periods of time, allowing for maximum freshness

“Our goal is not to be a mass producer of cannabis, but rather a supplier of quality cannabis,” Misle explains. “We really want to be known for our premium quality. There are going to be growing pains in any new industry. However, we’re learning from the mistakes of others, which has taught us to do some things differently.”

Growth, licenses and hope for CBD 

Citation has cultivation facilities in California, Washington State and British Columbia, Canada at various stages of development, all with the same goal of becoming certified organic producers. Citation also has fully operational extraction and production facilities in North Las Vegas at their Apex campus.

The company is developing two cultivation sites in British Columbia — one in Celista in the North Shuswap area with the potential for ten 10,000-sq.-ft. buildings, of which two 10,000-sq.-ft. buildings are near completion and the other, a 100-acre joint venture in Chase already approved for 486,000-sq.-ft. of cultivation.

In Washington State, the company has 13.8 acres of cannabis-zoned property, and in California’s Desert Hot Springs, Citation has two cultivation and production centers in the works. Both facilities in Washington and California will be further developed once the sites in British Columbia have been completed.

While cultivating its organic strains is the immediate priority, moving from a wholesale provider to a larger retail footprint is next.

“For us to be really profitable we have to be a seed-to-sale integrated company, so having a dispensary is on the top of our priority list,” Mohamed explains.

The company has seven retail licenses in Nevada that it could develop into dispensaries in the future and is looking at potentially purchasing some existing dispensaries as well. Selling directly into the retail market would potentially double their current $1-million monthly revenues in the state, with many organic products selling for about USD$3,000-$3,200/pound wholesale and climbing up to USD$8,300 retail.

In the future, Citation plans on expanding sales into additional marketplaces by white labelling their products and bringing other producers’ products into their stores. Interestingly, they are also tracking the emerging marketplace for CBD oil, a cannabis extract that has shown potential for numerous things. 

“We eventually hope to get into CBD,” Misle says. “It is on our radar and we are working on that as we speak.”

An extremely talented and knowledgeable team leads Citation. Misle, alone, has been involved in the cannabis sector since 2003 and played an integral role in the Nevada cultivation scene since legalization.

The company also boasts president and director, Rahim Mohamed, who’s 23-year international career in the private and public sector has propped him up to be instrumental in closing multiple mergers and acquisitions; and positioning Citation as one of the largest licensed footprint holders in the state of Nevada.

For investors learning about the company — based on its projections, Citation expects its total revenues in Nevada to hit over $350-million annually, upon completion of the entire build-out in both Pahrump and North Las Vegas. The company is on the rise, and it’s strategically making its way through the evolving cannabis sector.

With Citation’s brand portfolio, its flagship facilities in Nevada already generating revenue, paired with the company’s organic methodology and more, it is evident that Citation’s trajectory to become a leading powerhouse is on the horizon.

To learn more about Citation Growth Corp, see their website here.

For further information, contact Citation at 1-877-438-5448 — Extension 718.

This story was provided by Market One Media Group for commercial purposes.

Article Link

Kelowna, British Columbia–(Newsfile Corp. – November 6, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, is pleased to announce that Mr. Alnoor Nathoo has joined the Company’s board of directors. Mr. Nathoo brings with him a wealth of public and private company experience. Mr. Nathoo is principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada. Prior to that, Mr. Nathoo was an investment advisor with Global Securities Corporation. Mr. Nathoo currently sits on the board of Softlab9 Software Solutions Inc.

To make room on the board for Mr. Nathoo, Mr. Raman Gill has resigned from the board of directors. The Company would like to thank Mr. Gill for his services and contributions to the Company.

Rahim Mohamed, Director & President of Citation commented, “We are very pleased to welcome Mr. Nathoo to the board of Citation. Mr. Nathoo was instrumental in funding ACC Enterprises privately and continued to support Citation since the closing of the merger with ACC. I look forward to working with Mr. Nathoo as we continue to focus on the high growth Nevada cannabis market through our cultivation and extraction assets in Pahrump and Las Vegas.” 

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
RM@citationgrowth.com
1-877-438-5448 Extension 718

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Kelowna, British Columbia–(Newsfile Corp. – October 30, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, announces that it has completed a non-brokered private placement (the “Private Placement”) of 3,615,000 units at $0.30 per unit for gross proceeds of $1,084,500. Each unit consists of one common share and one-half of one share purchase warrant. Each whole warrant is exercisable into one common share at an exercise price of $0.60 per share for a period of two years expiring October 30, 2021. The warrants are subject to an accelerated expiry date if the trading price of the Company’s common shares closes at or above $1.00 per share for a period of ten consecutive trading days.

The proceeds from the Private Placement will be used for general working capital purposes.

All securities issued under the Private Placement are subject to a four month hold period expiring March 1, 2020.

Participation of insiders of the Company in the Private Placement constitutes a related party transaction as defined under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). Since the Company’s shares trade only on the CSE, the issuance of securities is exempt from the formal valuation requirements of Section 5.4 of MI 61-101 pursuant to Subsection 5.5(b) of MI 61-101 and exempt from the minority approval requirements of Section 5.6 of MI 61-101.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President 1-877-438-5448 Extension 718 RM@citationgrowth.com

Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other

recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Not an Offer or Solicitation:

This press release is not an offer of the Company’s securities for sale in the U.S. The securities may not be offered or sold in the U.S. absent registration or an available exemption from the registration requirements

of the U.S. Securities Act and applicable U.S. state securities laws. The Company will not make any public offering of its securities in the U.S. The Company’s securities have not been and will not be registered under the U.S. Securities Act.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW

Kelowna, British Columbia–(Newsfile Corp. – October 30, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company“), a licensed cannabis cultivator and producer, is pleased to announce that the Company has received approval from the debenture holders for the amendment (the “Amendment”) of the terms of the 10% unsecured convertible debentures (the “Debentures”) as previously announced in its news release dated October 28, 2019.

The following Amendments were approved by the Debenture holders holding over 74.94% of the aggregate outstanding principal amount of the Debentures:

1. The maturity date will be extended from October 23, 2019 to October 23, 2020;

2. All accrued and unpaid interest will be paid in common shares of the Company at market price on the date of issuance;

3. The conversion price will be reduced from $0.80 to $0.70 per unit subject to accelerated maturity if the trading price of the Company’s common shares closes at or above $1.05 per share for ten consecutive trading days;

4. The warrant exercise price will be reduced from $2.00 to $1.25 per share for a period of eighteen months expiring October 23, 2021, subject to acceleration if the trading price of the Company’s common shares closes at or above $1.88 per share for ten consecutive trading days; and

5. Howard Misle, CEO, agreed to personally pay the Debenture holders an additional $260,612 or 10% of the principal amount outstanding in shares when he receives his performance bonus shares.

All other terms of the Debentures remain the same.

In connection with the Amendment, the Company issued 635,642 common shares to settle accrued interests of $260,613 at a deemed price of $0.41 per share. The shares are subject to a four month plus 1 day hold period expiring February 29, 2020.

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed,
President RM@citationgrowth.com
1-877-438-5448 Extension 718

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com
www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its

intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is nota positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Not an Offer or Solicitation:

This press release is not an offer of the Company’s securities for sale in the U.S. The securities may not be offered or sold in the U.S. absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. The Company will not make any public offering of its securities in the U.S. The Company’s securities have not been and will not be registered under the U.S. Securities Act.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW

Below is our recent interview with Rahim Mohamed, President and Director of Citation Growth Corp:

Q: Could you provide our readers with a brief introduction to Citation Growth Corp?

A: Citation Growth Corp (CSE: CGRO; OTCQX: CGOTF) is a publicly traded company that focuses on cannabis cultivation and processing across various jurisdictions in North America. Citation has facilities and operations in Las Vegas and Pahrump, Nevada with licenses to build up to 569,600 square feet. We have a dispensary in Desert Hot Springs, along with licenses and properties in California and Washington. Our Canadian operations are in British Columbia with facilities being built in Celista. Citation is focussed on providing premium organic cannabis to consumers from all our facilities and we are the only company in the State of Nevada that has Triple-Certified Organic product.

Citation has five well established brands in Nevada (Fiore, Blunt Box, Gardens of WeEden and Superior) and we recently announced our new brand: Diamante Labs, a high-end extract product line, made with the company’s Fiore Triple-Certified Organic flower. This ultra premium brand will include Diamonds (high TCHa crystalline formations with fractionated terpene “sauce” added), live resin, sugar waxes and live resin vape pens. We are committed to cultivating and processing organic cannabis and using our extraction facility to provide premium products for consumers, all while staying dedicated to environmentally conscious methods of operation. More information about our brands can be found on our website at http://citationgrowth.com/brands/.

Q: What makes you stand out from your competition?

A: Citation is focussed on building a strong foundation which we see as cultivating and producing the best quality organic cannabis consumers can buy. We thrive on creating the Best Quality products as well as products that are Healthier for consumption by making Citation’s products free of any chemicals, herbicides, pesticides and fertilizers. Citation is the only company in the state of Nevada that is Triple-Certified Organic. The Triple Organic Certification consists of three separate certifications that have been issued to Citation by nationally recognized organic standard boards. These include: EnvirOrganic Farm Certification, Certified Kind, and Clean Green Certifications, which all verify that our cannabis is organic and produced following the most stringent industry standards.

Our Las Vegas crops are continually inspected, tested and sampled to verify that Citation is consistently upholding all requirements to hold these prestigious triple organic certifications. Our organic growing methods and top of the line genetics combined with our use of the most naturally occurring hydrocarbons in our extraction process makes our product some of the cleanest on the market. Citation Growth is focussed on setting a new standard for quality, cost and margin in all our operations and is already generating revenue.

Q: What is the biggest challenge you’ve faced in your business and how did you overcome it?

A: The cannabis sector is in its infancy and a new industry in general, so most cannabis companies are facing challenges. The entire industry itself is still growing and overcoming challenges, each company feels the effects of this.

For Citation, the biggest challenge was creating a brand that consumers recognized as premium organic cannabis with superior quality. Becoming a recognized brand takes time and we have been committed to showing consumers that we are dedicated to consistently cultivating and producing the best quality cannabis that consumers can buy. With the vape crisis and lung illnesses spreading rapidly, consumers are becoming more cognisant of the cannabis products they purchase. Consumers have started to learn more about organic cannabis, its production methods and its benefits. As a result of this, demand for Citation’s organic cannabis brands is steadily increasing, for all our products including our flower, extracts, and vape pens. Citation’s organic cannabis brands can now be found in 47 of 60 dispensaries in Nevada and our brands are becoming synonymous with premium quality organic cannabis.

Q: What are your plans for the future?

A: Presently, we are converting our current Pahrump facility to be certified organic and we plan to build out another 40,000 square feet of cultivation in Pahrump. Over time Citation will build out the entire 569,600 square feet in Nevada, but this will occur in various phases. In relation to our production facility in Nevada, we plan to eventually white label our products which allows us to maximize the use of our production facilities, increase revenue, raise awareness of our premium quality organic products, all while creating sustainability.

With Nevada operations up-and-running, Citation plans to get the Canadian facilities complete and operational in Celista, British Columbia, which will be a major milestone. Lastly, the company also plans to acquire or receive our own dispensary license in Las Vegas to be fully integrated from seed to sale and we will eventually strive to get into CBD production.

Q: What reasons would someone invest in Citation Growth Corp?

A: Citation has tremendous assets and upside potential but most importantly, the company’s revenue has started climbing. We have focussed on building a strong foundation of cultivation by consistently growing premium quality organic cannabis. By doing this it has allowed us to make sure that the mainstay of the company, cannabis, is reliable and thus able to generate consistent revenue. Our brands and our cost of production will help support and drive company sustainability and take this company and hopefully the entire cannabis sector to new levels. For those wanting any additional information please visit our website at http://citationgrowth.com/.

Link to Article

Kelowna, British Columbia–(Newsfile Corp. – October 28, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces that management of the Company and the debenture holders represented by Tim Johnson of Vernon, British Columbia, worked diligently over the last week to reach an agreement to amend the terms of the Convertible Debentures in the principal amount of $2.6 million which matured on October 23, 2019 (the “Debentures”). The Debentures are unsecured, bear interest at 10% per annum and are convertible into units of the Company at a price of $0.80 per unit. Each unit consists of one common share and one warrant exercisable at $2.00 per share until October 23, 2019.

The parties agreed to amend the Debentures on the following terms:

  1. The maturity date will be extended from October 23, 2019 to October 23, 2020;
  2. All accrued and unpaid interest will be paid in common shares of the Company at market price on the date of issuance. Such shares will be subject to a four month
  3. plus 1 day hold period; The conversion price will be reduced from $0.80 to $0.70 per unit subject to accelerated maturity if the Company’s common shares trade above $1.05 per share for ten consecutive trading days;
  4. The warrant exercise price will be reduced from $2.00 to $1.25 per share for a period of eighteen months expiring April 23, 2021, subject to acceleration if the Company’s common shares trade above $1.88 per share for ten consecutive trading days; and
  5. As an act of good faith, Howard Misle, CEO, agreed to personally pay the Debenture holders $260,000 or 10% of the principal amount outstanding in shares when he receives his performance bonus shares.

All other terms of the Debentures remain the same.

Pursuant to the terms of the Debentures, the amendment is subject to the Company receiving written consents of at least 66.67% of the Debenture holders.

Howard Misle, CEO, stated, “I would like to thank Mr. Johnson for his time and cooperation this past week and our Debenture holders for their continued support. Our ability to come to terms resulted in a positive outcome for the Company and I look forward to conducting more business with Mr. Johnson and his associates in the future.”

Tim Johnson, Debenture holder, commented, “Mr. Misle invited me and my wife to tour both the Pahrump and Apex growing facilities in Nevada last week. We were very impressed by the motivated staff members, the clean and well organized growing operations and the level of progress they have achieved. The real hidden gem in this deal is the hard driving task master, Howard Misle. We left our meeting with him feeling even more confident in our vested position.”

Rahim Mohamed added, “Management of Citation is extremely pleased with the overall outcome and we now can all go back to focusing on building the Company and increasing shareholder value.”

About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information:

Rahim Mohamed, President
RM@citationgrowth.com
1-877-438-5448 Extension 718

Paul Searle, Corporate Communications
1-877-438-5448 Extension 714
psearle@citationgrowth.com

www.citationgrowth.com

Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements:

This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products; future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate.

Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

Not an Offer or Solicitation:

This press release is not an offer of the Company’s securities for sale in the U.S. The securities may not be offered or sold in the U.S. absent registration or an available exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. The Company will not make any public offering of its securities in the U.S. The Company’s securities have not been and will not be registered under the U.S.

Securities Act.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW

Las Vegas, Nevada – (Newsfile Corp. – October 23, 2019) – Citation Growth Corp. (CSE: CGRO) (OTCQX: CGOTF) (“Citation” or the “Company”), a licensed cannabis cultivator and producer, announces the completion of its production facility and will focus on obtaining Organic Certification for its Pahrump facility. The new production facility is fully staffed and trained. All equipment has successfully been installed and tested and is in full working order. The Company anticipates deliveries of both their DIAMANTE and SUPERIOR product lines to dispensaries within the next 21 days. Citation is now in a position where they can upcycle its trim, popcorn and flower, and achieve 2x to 3x revenue from converting into high-end extracts. Howard Misle, CEO of Citation commented, “Pahrump organic certification is underway. We have taken great strides in converting this facility into a Certified-Organic facility for several months now. With increasing concerns around the inhalation of chemicals, Citation found it necessary to stay ahead of the curve and switch completely to organic to provide our buyers and consumers with the BEST QUALITY products with no chemicals, herbicides and/or pesticides.”

The Pahrump facility is now ready for inspection to become certified. Citation’s North Las Vegas facility remains the only Nevada facility to be triple organic certified, giving the Company the opportunity to realize higher margins on its products.

Our North Las Vegas triple organic certified facility is approximately 10,000 square feet in size. Once certified, Pahrump will give Citation another 26,500 square feet of certified organic cultivation space in Nevada. Adding Pahrump’s potential licensed footprint to Las Vegas’ potential licensed capacity makes Citation one of the largest licensed footprint holders in the state of Nevada with 569,600 square feet of cultivation and processing, once all phases are built out and the sites are fully operational. About Citation Growth Corp.

Citation Growth Corp. is a publicly traded company that has been investing in the medical and recreational cannabis space since 2014. Citation has rapidly expanded its operating portfolio to include cultivation, production, and dispensary locations in key North American state-legal jurisdictions and is seeking expansion opportunities worldwide.

For Further Information: Rahim Mohamed, President RM@citationgrowth.com 1-877-438-5448 Extension 718 Paul Searle, Corporate Communications 1-877-438-5448 Extension 714 psearle@citygatecap.com www.citationgrowth.com Stock Exchanges:

Citation trades in Canada, under the ticker symbol “CGRO” on the CSE, and in the U.S., under the ticker symbol “CGOTF” on the OTCQX Best Market (the “OTCQX”). The Company also trades on other recognized platforms in Europe including Frankfurt, Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin. Neither the CSE nor its Regulation Services Provider, nor the OTCQX has approved nor disapproved the contents of this press release. Neither the CSE, nor the OTCQX accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements: This news release contains forward-looking statements that relate to our current expectations and views of future events. These statements relate to future events or future performance. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “become”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. Forward-looking statements may also include, among other things, statements about the Company’s: future business strategy; operations and growth strategies; expectations of obtaining licenses and permits; expectations regarding expenses, sales and operations; future customer concentration; anticipated cash needs and estimates regarding capital requirements and the need for additional financing; ability to raise future financing; completion of all proposed site phases; the ability to expand into other states; expectations of operational efficiencies; total processing capacity; the ability to anticipate the future needs of customers; plans for future products and enhancements of existing products;

future growth strategy and growth rate; future intellectual property; regulatory approvals and other matters; and anticipated trends and challenges in the markets in which the Company may operate. Such forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: business, economic and capital market conditions; the ability to manage the Company’s operating expenses, which may adversely affect the Company’s financial condition; the Company’s ability to remain competitive; regulatory uncertainties; market conditions and the demand and pricing for our products; exchange rate fluctuations; security threats; the Company’s relationships with its customers, distributors and business partners; the Company’s ability to attract, retain and motivate qualified personnel; industry competition; the impact of technology changes on the Company’s products and industry; the Company’s ability to successfully maintain and enforce its intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of litigation that could materially and adversely affect our business; the Company’s ability to manage its working capital; and the Company’s dependence on key personnel. The Company is not a positive cash flow company and it may not actually achieve its plans, projections, or expectations (the Company has a history of losses).

Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future event or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION OR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW